BCAX vs HUBB · $1.51B cap vs P/E 28, rev $1.49B
Bicara Therapeutics Inc. Common Stock (BCAX) versus Hubbell Inc (HUBB) — a side-by-side from cached financials, not a winner call.
Bicara Therapeutics Inc. Common Stock (BCAX) is a biotechnology company listed on NASDAQ.
Hubbell Inc (HUBB) is a electrical equipment & parts company listed on US.
BCAX does not have a complete income-statement cache yet.
Latest reported HUBB revenue for 2025-12-31 was $1.49B. Net income was $224.2M. Revenue was down 73.5% from 2024-12-31 to 2025-12-31. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
BCAX currently screens at market cap $1.51B. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
Not investment advice. Open the BCAX and HUBB stock pages for the full models.
Not investment advice.